The most commonly mutated genes include NPM1, CEBPA, TET2, IDH, DNMT3A and FLT3. Mutations in the receptor tyrosine kinase FLT3 occurs in more than 30% of AML patients [1]. The gene discussed is NTRK1; the disease is acute myeloid leukemia.